A detailed history of Us Bancorp \De\ transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 5,730 shares of IONS stock, worth $219,229. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,730
Previous 11,050 48.14%
Holding current value
$219,229
Previous $526,000 56.46%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$40.06 - $51.86 $213,119 - $275,895
-5,320 Reduced 48.14%
5,730 $229,000
Q2 2024

Aug 06, 2024

SELL
$36.45 - $47.7 $31,966 - $41,832
-877 Reduced 7.35%
11,050 $526,000
Q1 2024

May 07, 2024

SELL
$42.03 - $53.55 $336 - $428
-8 Reduced 0.07%
11,927 $517,000
Q4 2023

Feb 09, 2024

SELL
$43.39 - $51.63 $61,743 - $73,469
-1,423 Reduced 10.65%
11,935 $603,000
Q3 2023

Nov 03, 2023

SELL
$38.5 - $47.13 $25,487 - $31,200
-662 Reduced 4.72%
13,358 $605,000
Q2 2023

Aug 09, 2023

SELL
$34.73 - $43.33 $73,002 - $91,079
-2,102 Reduced 13.04%
14,020 $575,000
Q1 2023

May 09, 2023

BUY
$33.58 - $41.2 $43,721 - $53,642
1,302 Added 8.79%
16,122 $576,000
Q4 2022

Feb 13, 2023

SELL
$37.12 - $46.52 $51,151 - $64,104
-1,378 Reduced 8.51%
14,820 $559,000
Q3 2022

Oct 27, 2022

SELL
$36.54 - $48.66 $41,107 - $54,742
-1,125 Reduced 6.49%
16,198 $717,000
Q2 2022

Aug 01, 2022

SELL
$31.71 - $43.0 $131,120 - $177,805
-4,135 Reduced 19.27%
17,323 $641,000
Q1 2022

May 11, 2022

BUY
$29.88 - $37.04 $70,008 - $86,784
2,343 Added 12.26%
21,458 $795,000
Q4 2021

Feb 11, 2022

BUY
$25.61 - $35.1 $69,966 - $95,893
2,732 Added 16.68%
19,115 $582,000
Q3 2021

Nov 10, 2021

BUY
$33.54 - $40.55 $79,657 - $96,306
2,375 Added 16.95%
16,383 $550,000
Q2 2021

Aug 05, 2021

BUY
$34.54 - $47.25 $14,575 - $19,939
422 Added 3.11%
14,008 $558,000
Q1 2021

Apr 28, 2021

BUY
$42.51 - $63.78 $470,500 - $705,917
11,068 Added 439.56%
13,586 $610,000
Q4 2020

Feb 04, 2021

BUY
$45.3 - $60.27 $40,905 - $54,423
903 Added 55.91%
2,518 $142,000
Q3 2020

Nov 10, 2020

BUY
$47.45 - $62.95 $12,004 - $15,926
253 Added 18.58%
1,615 $76,000
Q2 2020

Aug 07, 2020

SELL
$46.85 - $61.05 $42,961 - $55,982
-917 Reduced 40.24%
1,362 $80,000
Q1 2020

May 13, 2020

BUY
$41.6 - $63.4 $12,230 - $18,639
294 Added 14.81%
2,279 $107,000
Q4 2019

Feb 04, 2020

SELL
$53.85 - $65.27 $23,047 - $27,935
-428 Reduced 17.74%
1,985 $120,000
Q3 2019

Nov 08, 2019

BUY
$59.06 - $72.15 $24,509 - $29,942
415 Added 20.77%
2,413 $145,000
Q2 2019

Aug 13, 2019

SELL
$62.09 - $86.14 $1,614 - $2,239
-26 Reduced 1.28%
1,998 $129,000
Q1 2019

May 08, 2019

BUY
$52.92 - $81.17 $18,257 - $28,003
345 Added 20.55%
2,024 $164,000
Q4 2018

Feb 13, 2019

SELL
$43.37 - $59.54 $83,964 - $115,269
-1,936 Reduced 53.55%
1,679 $91,000
Q3 2018

Nov 01, 2018

SELL
$42.88 - $53.7 $60,289 - $75,502
-1,406 Reduced 28.0%
3,615 $186,000
Q2 2018

Aug 08, 2018

SELL
$40.53 - $50.7 $32,180 - $40,255
-794 Reduced 13.65%
5,021 $210,000
Q1 2018

May 08, 2018

BUY
$44.08 - $55.05 $15,648 - $19,542
355 Added 6.5%
5,815 $257,000
Q4 2017

Feb 02, 2018

BUY
$50.3 - $64.39 $15,492 - $19,832
308 Added 5.98%
5,460 $274,000
Q3 2017

Nov 13, 2017

BUY
$45.56 - $59.57 $234,725 - $306,904
5,152
5,152 $261,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.43B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.